Newsletters Joni Henderson 10/21/24 Joni Henderson 10/21/24 C2N at CTAD 2024 in Madrid Read More Joni Henderson 9/4/24 Joni Henderson 9/4/24 JAMA Published Landmark Clinical Study on Alzheimer’s Disease Diagnosis Using the PrecivityAD2™ Blood Test Read More Joni Henderson 7/16/24 Joni Henderson 7/16/24 C2N at AAIC in Philadelphia July 28–Aug. 1 C2N at AAIC in Philadelphia July 28–Aug. 1 Read More Lee Q 10/18/23 Lee Q 10/18/23 Join our C₂N Diagnostics team at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) October 24 – 27 in Boston Read More David Feinstein 11/17/22 David Feinstein 11/17/22 Join our C₂N Diagnostics team at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco, November 29 – December 2 Read More Guest User 10/21/22 Guest User 10/21/22 C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments Read More Lee Q 4/23/21 Lee Q 4/23/21 PrecivityAD™ Test Success Leads to Attention and Growth Read More Lee Q 12/21/20 Lee Q 12/21/20 2020 Marks a Year of Achievement Read More Subscribe to our newsletter. Sign up with your email address to receive news and updates. Email Address Sign Up We respect your privacy. Thank you!
Joni Henderson 9/4/24 Joni Henderson 9/4/24 JAMA Published Landmark Clinical Study on Alzheimer’s Disease Diagnosis Using the PrecivityAD2™ Blood Test Read More
Joni Henderson 7/16/24 Joni Henderson 7/16/24 C2N at AAIC in Philadelphia July 28–Aug. 1 C2N at AAIC in Philadelphia July 28–Aug. 1 Read More
Lee Q 10/18/23 Lee Q 10/18/23 Join our C₂N Diagnostics team at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) October 24 – 27 in Boston Read More
David Feinstein 11/17/22 David Feinstein 11/17/22 Join our C₂N Diagnostics team at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco, November 29 – December 2 Read More
Guest User 10/21/22 Guest User 10/21/22 C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments Read More
